This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference

DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference at 4:20PM ET on Thursday, June 5, 2025. A live webcast will be available using this weblink: https://wsw.com/webcast/jeff319/til/1708376.

About Instil Bio
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil's lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumors. For more information, visit www.instilbio.com.

Forward-Looking Statements
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements speak only as the date hereof, and Instil disclaims any obligation to update these statements except as may be required by law.

Contacts:
Investor Relations:
1-972-499-3350
investorrelations@instilbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.97
+2.76 (1.23%)
AAPL  265.69
+2.87 (1.09%)
AMD  254.10
+1.18 (0.47%)
BAC  52.81
+0.24 (0.47%)
GOOG  267.06
+6.55 (2.51%)
META  751.13
+12.77 (1.73%)
MSFT  532.64
+9.03 (1.73%)
NVDA  190.94
+4.68 (2.51%)
ORCL  282.93
-0.40 (-0.14%)
TSLA  453.63
+19.91 (4.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.